Paul Hartmann AGFRA:PHH2 +1.49%61 EV-to-FCF is 6.27 as of Jul. 10, 2026, which is 60% below its 10-year median of 15.85. GuruFocus rates FRA:PHH2 with a GF Score™ of 61/100 and a GF Value™ of €226.41 (Fairly Valued). The stock has 4 warning signs investors should review. Among 414 Medical Devices & Instruments companies, Paul Hartmann AG ranks better than 90.58% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Paul Hartmann AG's Enterprise Value is €970 Mil.
Paul Hartmann AG's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was €155 Mil. Therefore, Paul Hartmann AG's EV-to-FCF for today is 6.27.
The historical rank and industry rank for Paul Hartmann AG's EV-to-FCF or its related term are showing as below:
FRA:PHH2'
s EV-to-FCF Range Over the Past 10 Years
Min: -8.51 Med: 15.85 Max: 916.93
Current: 6.27
During the past 13 years, the highest EV-to-FCF of Paul Hartmann AG was 916.93. The lowest was -8.51. And the median was 15.85.
FRA:PHH2's EV-to-FCF is ranked better than 90.58% of 414
companies
in the Medical Devices & Instruments industry
Industry Median: 23.19
vs FRA:PHH2: 6.27
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Paul Hartmann AG's PE Ratio (TTM) for today is calculated as:
Paul Hartmann AG's share price for today is €205.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Paul Hartmann AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was €17.230.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Paul Hartmann AG EV-to-FCF Related Terms
Paul Hartmann AG EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Paul Hartmann AG's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Paul Hartmann AG's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Paul Hartmann AG EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Paul Hartmann AG's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Paul Hartmann AG's EV-to-FCF falls into.
Paul Hartmann AG's current Enterprise Value is €970 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Paul Hartmann AG's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was €155 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Paul Hartmann AG (FRA:PHH2) has a EV-to-FCF of 6.27 as of Jul. 10, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Paul Hartmann AG and its competitors. This is 60% below median its historical median of 15.85. According to the industry distribution chart, Paul Hartmann AG ranks #39 out of 414 companies in the Medical Devices & Instruments industry, placing it in the top 9.4%.
Is Paul Hartmann AG's EV-to-FCF too high?
Paul Hartmann AG's current EV-to-FCF of 6.27 is 60% below median its 10-year median of 15.85. The Medical Devices & Instruments industry median EV-to-FCF is 23.19. Paul Hartmann AG's value of 6.27 is 73% below this industry median. Based on the distribution chart, Paul Hartmann AG ranks #39 out of 414 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Paul Hartmann AG has a GF Score™ of 61/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Paul Hartmann AG's EV-to-FCF compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Paul Hartmann AG ranks #39 out of 414 companies for EV-to-FCF. This places Paul Hartmann AG in the top 9% of its industry — outperforming the majority of peers. The industry median EV-to-FCF is 23.19. Paul Hartmann AG's value of 6.27 is 73% below this benchmark. While the company's 10-year median is 15.85 vs. the industry median of 23.19, Paul Hartmann AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 23.19, based on 414 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Paul Hartmann AG's current EV-to-FCF of 6.27 is 73% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Paul Hartmann AG and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 23.19 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Paul Hartmann AG's current EV-to-FCF is 6.27, which is 60% below median its own 10-year median of 15.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Paul Hartmann AG stock overvalued right now?
Based on GuruFocus' analysis, Paul Hartmann AG (FRA:PHH2) is currently considered Fairly Valued. The stock's GF Value™ is €226.41, compared to a current price of €205.00 — trading 9.5% below its estimated fair value. The current EV-to-FCF is 6.27, which is 60% below median its 10-year median of 15.85 and 73% below the Medical Devices & Instruments industry median of 23.19. Paul Hartmann AG's overall GF Score™ is 61/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Paul Hartmann AG (FRA:PHH2), the current EV-to-FCF is 6.27 as of Jul. 10, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Paul Hartmann AG (FRA:PHH2) Overvalued in 2026?
Based on GuruFocus' analysis, Paul Hartmann AG stock appears to be undervalued.
The current stock price of €205.00 is trading 9.5% below its estimated GF Value™ of €226.41.
GuruFocus considers Paul Hartmann AG to be Fairly Valued.
Key valuation signals for FRA:PHH2:
EV-to-FCF: 6.27 (60% below median its 10-year median of 15.85)
GF Value™: €226.41 vs. price of €205.00 (9.5% below fair value)
Industry Position: 73% below the Medical Devices & Instruments median (#39 of 414)
No single metric tells the full story. See the FRA:PHH2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Paul Hartmann AG engages in the production of medical and hygiene products. It operates through Wound Management, Incontinence Management and Infection Management and other segments. The Wound segment comprises wound dressing and treatment, compression therapy, first aid, immobilization, and diagnostics. The Incontinence segment provides incontinence hygiene, patient care, and medical skin care. The Infection segment consists of custom procedure trays, surgical draping systems, disposable surgical instruments, and disinfectants. The Other activities include activities in cotton-wool products, medical consumer goods and pharmaceutical products and others. All the activities are functioned through the region of US and derive revenue through the sale of medical and hygiene products.
61GF Score
Get the complete analysis for FRA:PHH2
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:PHH2 has been successfully added to your 
